BRÈVE publiée le 23/07/2024 à 11:05, il y a 1 mois 28 jours Funding Circle Announces Change in Director Details Regulatory Compliance Board Change Funding Circle Helen Beck Picton Property
COMMUNIQUÉ DE PRESSE publié le 23/07/2024 à 11:00, il y a 1 mois 28 jours Funding Circle Plc: Notification of Change of Director Details Funding Circle Plc announces notification of change in director details with Helen Beck appointed as Non-Executive Director of Picton Property Income Limited Funding Circle Plc Non-Executive Director Helen Beck Director Details Picton Property Income Limited
BRÈVE publiée le 22/07/2024 à 18:49, il y a 1 mois 29 jours Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback FCA Regulations Funding Circle
BRÈVE publiée le 22/07/2024 à 18:49, il y a 1 mois 29 jours Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Actions Ordinaires Bourse De Londres Cercle De Financement Règlements De La FCA
COMMUNIQUÉ DE PRESSE publié le 22/07/2024 à 18:44, il y a 1 mois 29 jours Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of ordinary shares, totaling 121,052 shares, at prices ranging from 106.50p to 110.50p on the London Stock Exchange London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRÈVE publiée le 19/07/2024 à 18:03, il y a 2 mois 1 jour Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Bourse De Londres Cercle De Financement Deutsche Numis Détails De La Transaction
BRÈVE publiée le 19/07/2024 à 18:03, il y a 2 mois 1 jour Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Transaction Details Funding Circle Deutsche Numis
COMMUNIQUÉ DE PRESSE publié le 19/07/2024 à 17:58, il y a 2 mois 1 jour Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 207,835 ordinary shares at prices ranging from 106.50p to 108.50p per share London Stock Exchange Ordinary Shares Purchase Cancellation Funding Circle Plc
BRÈVE publiée le 18/07/2024 à 19:42, il y a 2 mois 2 jours Funding Circle Plc: Share Buyback Transaction on LSE London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle
BRÈVE publiée le 18/07/2024 à 19:42, il y a 2 mois 2 jours Funding Circle Plc : Opération de rachat d'actions sur le LSE Rachat D'actions Actions Ordinaires Bourse De Londres Cercle De Financement Annulation
Publié le 20/09/2024 à 17:40, il y a 11 heures 21 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 11 heures 21 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 5 heures 21 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 5 heures 31 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 6 heures 1 minute AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 6 heures 31 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 6 heures 46 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 6 heures 3 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 8 heures 1 minute Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 8 heures 46 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 9 heures 11 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 9 heures 14 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma